Kimberly Dodd
Director, Veterinary Diagnostic Laboratory | Michigan State University
East Lansing, MI, UNITED STATES
Dr. Dodd is an internationally recognized expert in laboratory diagnostics and outbreak response for emerging infectious diseases.
Biography
Dr. Dodd is an internationally recognized expert in laboratory diagnostics and outbreak response for emerging infectious diseases. While director of the USDA APHIS reference laboratory for foreign animal diseases, she expanded U.S. preparedness to rapidly detect high consequence animal diseases and developed a nationwide graduate training program to train new laboratory diagnosticians. Dodd also has worked extensively in Africa to strengthen laboratory and surveillance capacity for zoonotic disease threats. She is a champion for the critical role veterinary diagnostic laboratories play in protecting public and animal health locally, nationally, and globally and is passionate about supporting the development of the next generation of veterinarians and laboratorians.
Areas of Expertise (10)
Disease Pathogenesis
Vaccine Development
Emerging Diseases
Laboratory Diagnostics
Outbreak Responses
Zoonotic Diseases
Animal Disease
Public Health
Infectious Diseases
Foreign Animal Diseases
Accomplishments (5)
Young Alumna Award, UC Davis Alumni Association
2021
Administrator's Award, USDA APHIS
2020
Market and Regulatory Program Undersecretary's Award, USDA
2020
Meritorious Honor Award for Service, West Africa Ebola Outbreak, US State Department
2015
Charles C. Shepard Award in Laboratory Science, Centers for Disease Control and Prevention
2011
Education (4)
University of California-Davis: DVM, Small Animal Medicine
University of California-Davis: Ph.D., Comparative Pathology
University of Virginia: M.S., Disease Ecology and Population Biology
University of Virginia: B.A., Psychology
Affiliations (2)
- Centers for Disease Control and Prevention : Guest Researcher, Viral Special Pathogens Branch, 2009 - 2013
- Metabiota : Senior Scientist, Special Projects, 2015 - 2017
Links (3)
News (2)
Ask the Expert: COVID cases in animals
MSU Today online
2021-10-19
Early in the pandemic, Michigan State University's College of Veterinary Medicine shared what was known at that time about animals and SARS-CoV-2, the virus that causes COVID-19 in humans. With the Delta variant’s spread and additional reports of SARS-CoV-2 infections in animals, Kimberly Dodd, director of the MSU Veterinary Diagnostic Laboratory, revisits the topic and provides updates as new cases are discovered.
New director of MSU Veterinary Diagnostic Laboratory named
MSU Today online
2021-08-31
“During my time as the director of a federal reference laboratory, I saw firsthand the extraordinary contributions of academic veterinary diagnostic laboratories in support of animal and public health,” Dodd said. “The MSU VDL is a leader in the field, with exceptional faculty and staff, and I look forward to leading the VDL and supporting an expansion of its mission and impact — locally, nationally and globally.”
Patents (1)
Rift valley fever virus replicon particles and use thereof
WO2013192144A2
2013 (with Brian H. Bird, Cesar G. Albarino and Stuart T. Nichol) Disclosed herein is a robust system for the reverse genetics generation of a Rift Valley fever (RVF) virus replicon particle (VRPRVF) vaccine candidate. VRPRVF can actively synthesize viral RNA and proteins, but lack structural glycoprotein genes, preventing spread within immunized individuals and reducing the risk of vaccine-induced pathogenicity. Is it disclosed herein that VRPRVF immunization is both safe and efficacious, resulting in a robust immune response that is protective against RVF virus challenge within 24 hours of immunization. Provided herein are VRPRVF, methods of producing VRPRVF, and method of using VRPRVF for immunization against RVF virus infection.
Journal Articles (5)
Evaluation of oral fluid as an aggregate sample for early detection of African swine fever virus using four independent pen-based experimental studies
Transboundary and Emerging DiseasesKalhari Goonewardene, Chungwon J Chung, Melissa Goolia, Leslie Blakemore, Andrew Fabian, Fawzi Mohamed, Charles Nfon, Alfonso Clavijo, Kimberly A Dodd, Aruna Ambagala
2021 The sustained spread of African swine fever (ASF) virus throughout much of the world has made ASF a global animal health priority, with an increased emphasis on enhancing preparedness to prevent, detect and respond to a potential outbreak of ASF virus (ASFV).
Outbreak of rabbit hemorrhagic disease virus 2 in the southwestern United States: first detections in southern California
Journal of Veterinary Diagnostic InvestigationJavier Asin, Akinyi C Nyaoke, Janet D Moore, Viviana Gonzalez-Astudillo, Deana L Clifford, Emma L Lantz, Andrea B Mikolon, Kimberly A Dodd, Beate Crossley, Francisco A Uzal
2021 An outbreak of rabbit hemorrhagic disease virus 2 (RHDV2)-associated disease occurred in the southwestern United States following its first detection in New Mexico in March 2020.
Coding-Complete Genome Sequences of Emerging Rabbit Hemorrhagic Disease Virus Type 2 Isolates Detected in 2020 in the United States
Microbiology Resource AnnouncementsVK O’Donnell, L Xu, K Moran, F Mohamed, T Boston, SJ Pauszek, DA Vierra, B Faburay, KA Dodd, RW Barrette
2021 Five rabbit hemorrhagic disease virus type 2 (RHDV2) coding-complete genome sequences were obtained from the livers of domestic and wild rabbits during the 2020 outbreak in the United States. These represent the first available RHDV2 sequences from the United States.
Validation of a binary ethylenimine (BEI) inactivation procedure for biosafety treatment of foot-and-mouth disease viruses (FMDV), vesicular stomatitis viruses (VSV), and swine vesicular disease virus
Veterinary MicrobiologyPing Wu, Yelitza Y Rodríguez, Benjamin J Hershey, Yadata Tadassa, Kimberly A Dodd, Wei Jia
2021 Binary ethylenimine (BEI) has been widely used as a virucide to inactivate viruses. For regulatory exclusion of a select agent, the United States Federal Select Agent Program (FSAP) requires an inactivation procedure that renders a select agent non-viable but allows the select agent to retain antigenic characteristics for future use must be validated, and the inactivated agent must be confirmed by a viability testing.
Development of a real-time PCR assay for detection of African swine fever virus with an endogenous internal control
Transboundary and Emerging DiseasesYin Wang, Lizhe Xu, Lance Noll, Colin Stoy, Elizabeth Porter, Jinping Fu, Yuan Feng, Lalitha Peddireddi, Xuming Liu, Kimberly A Dodd, Wei Jia, Jianfa Bai
2020 Real-time PCR assays are highly sensitive, specific and rapid techniques for the identification of ASF virus (ASFV) Although an ASFV p72 gene-based real-time PCR assay (a.k.a. the Zsak assay) has been widely used for ASFV detection, several more ASFV whole genome sequences have become available in the 15 years since the design of the Zsak assay.
